Literature DB >> 9238629

The use of a combinatorial library method to isolate human tumor cell adhesion peptides.

M E Pennington1, K S Lam, A E Cress.   

Abstract

Tumor cell progression is dependent in part on the successful adhesive interactions of the cells with the extracellular matrix. In this study, a new approach is described to isolate linear peptide ligand candidates involved in cellular adhesion. A synthetic combinatorial peptide library based on the 'one-bead-one-peptide' concept was incubated with live human prostate cancer cells for 90 min at 37 degrees C. The peptide bead coated with a monolayer of cells was then isolated for microsequencing. The DU145 (DU-H) cells were chosen since they have been previously characterized as containing elevated levels of a laminin receptor for cell adhesion, the alpha 6 beta 1 integrin on the cell surface. The use of a function-blocking antibody (GoH3) allows for the detection of peptides which are alpha 6-specific ligand candidates. From two different libraries (linear 9-mer and 11-mer) of a total of 1,500,000 beads, 68 peptide beads containing attached cells were isolated. These positive beads were then retested to determine the ability of the GoH3 antibody to block binding of the cells to the peptide beads. The alpha 6 integrin candidate peptide beads (five in total) were recovered and two of the beads were microsequenced. These two peptides, RU-1 (LNIVS-VNGRHX) and RX-1 (DNRIRLQAKXX), resemble the previously reported active peptide sequences (GD-2 and AG-73) from native laminin. The RU-1, RX-1 and AG-73 peptides were tested for their ability to support cell attachment and to bind the cell surface of DU-H prostate carcinoma cells in suspension using fluorescence-activated cell-sorting (FACS) analysis. Both RU-1 and AG-73 peptides supported cellular attachment within 1 h. In contrast, after 1 h, EHS laminin supported both cellular attachment and spreading. The RX-1 peptide exhibited only weak binding to the DU-H prostate carcinoma cells. FACS analysis indicated that AG-73 peptide attached to tumor cell surfaces over a range of concentrations, whereas the RU-1 peptide showed a homogeneous concentration required for attachment. The described strategy for screening a random peptide library offers three advantages: (i) ligands for conformationally sensitive receptors of adhesion can be isolated using live cells; (ii) specific binding can be selected for using function-blocking antibodies; and (iii) peptides supporting adhesion independent of spreading properties can be distinguished. In principle, specific adhesive peptides without prior knowledge of the sequence could be isolated for any epithelial cell surface receptor for which a function-blocking reagent is available.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9238629     DOI: 10.1007/bf01718696

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  46 in total

1.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

2.  General method for rapid synthesis of multicomponent peptide mixtures.

Authors:  A Furka; F Sebestyén; M Asgedom; G Dibó
Journal:  Int J Pept Protein Res       Date:  1991-06

Review 3.  One-bead-one-structure combinatorial libraries.

Authors:  M Lebl; V Krchnák; N F Sepetov; B Seligmann; P Strop; S Felder; K S Lam
Journal:  Biopolymers       Date:  1995       Impact factor: 2.505

4.  Biosynthesis and secretion of laminin and S-laminin by human prostate carcinoma cell lines.

Authors:  I Rabinovitz; A E Cress; R B Nagle
Journal:  Prostate       Date:  1994-08       Impact factor: 4.104

5.  Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands.

Authors:  H Bonkhoff; U Stein; K Remberger
Journal:  Hum Pathol       Date:  1993-03       Impact factor: 3.466

6.  Role of laminin-binding integrin in the invasion of basement membrane matrices by fibrosarcoma cells.

Authors:  D M Ramos; Y F Cheng; R H Kramer
Journal:  Invasion Metastasis       Date:  1991

Review 7.  Osteolytic bone metastasis in breast cancer.

Authors:  T Yoneda; A Sasaki; G R Mundy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma.

Authors:  R B Nagle; J D Knox; C Wolf; G T Bowden; A E Cress
Journal:  J Cell Biochem Suppl       Date:  1994

9.  Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane.

Authors:  S Dedhar; R Saulnier; R Nagle; C M Overall
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

View more
  8 in total

1.  Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5.

Authors:  Thomas C Sroka; Michael E Pennington; Anne E Cress
Journal:  Carcinogenesis       Date:  2006-03-14       Impact factor: 4.944

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  The minimum element of a synthetic peptide required to block prostate tumor cell migration.

Authors:  Thomas C Sroka; Jan Marik; Michael E Pennington; Kit S Lam; Anne E Cress
Journal:  Cancer Biol Ther       Date:  2006-11-30       Impact factor: 4.742

4.  MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myeloma.

Authors:  Anthony W Gebhard; Priyesh Jain; Rajesh R Nair; Michael F Emmons; Raul F Argilagos; John M Koomen; Mark L McLaughlin; Lori A Hazlehurst
Journal:  Mol Cancer Ther       Date:  2013-09-18       Impact factor: 6.261

Review 5.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

6.  Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β-hairpin-like scaffold, MTI-101.

Authors:  Priyesh Jain; David B Badger; Yi Liang; Anthony W Gebhard; Daniel Santiago; Philip Murray; Sridhar R Kaulagari; Ted J Gauthier; Rajesh Nair; MohanRaja Kumar; Wayne C Guida; Lori A Hazlehurst; Mark L McLaughlin
Journal:  Pept Sci (Hoboken)       Date:  2020-10-09

Review 7.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

8.  A novel nucleolin-binding peptide for Cancer Theranostics.

Authors:  Jae-Hyun Kim; Chanhyung Bae; Min-Jung Kim; In-Hye Song; Jae-Ha Ryu; Jang-Hyun Choi; Choong-Jae Lee; Jeong-Seok Nam; Jae Il Kim
Journal:  Theranostics       Date:  2020-07-14       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.